Equity

Corporate Results

Integrated Proteins standalone net profit declines 50.00% in the March 2024 quarter
(27-Apr-2024, 07:27 Hours IST)  
Net profit of Integrated Proteins declined 50.00% to Rs 0.02 crore in the quarter ended March 2024 as against Rs 0.04 crore during the previous quarter ended March 2023. Sales rose 41.18% to Rs 0.24 crore in the quarter ended March 2024 as against Rs 0.17 crore during the previous quarter ended March 2023.

For the full year,net profit rose 200.00% to Rs 0.09 crore in the year ended March 2024 as against Rs 0.03 crore during the previous year ended March 2023. Sales rose 41.18% to Rs 0.24 crore in the year ended March 2024 as against Rs 0.17 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
?Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales0.240.17 41 0.240.17 41
OPM %-20.830 --50.00-52.94 -
PBDT0.080.04 100 0.130.07 86
PBT0.080.05 60 0.100.04 150
NP0.020.04 -50 0.090.03 200

Powered by Capital Market - Live News

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)